Oxbow Advisors LLC Buys 9,078 Shares of Nutrien Ltd. $NTR

Oxbow Advisors LLC increased its position in Nutrien Ltd. (NYSE:NTR) by 6.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 152,059 shares of the company’s stock after buying an additional 9,078 shares during the period. Nutrien accounts for approximately 1.0% of Oxbow Advisors LLC’s investment portfolio, making the stock its 22nd biggest holding. Oxbow Advisors LLC’s holdings in Nutrien were worth $11,474,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in NTR. Montag A & Associates Inc. boosted its holdings in Nutrien by 310.7% in the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock worth $26,000 after acquiring an additional 320 shares in the last quarter. Sfam LLC acquired a new stake in Nutrien in the fourth quarter valued at approximately $37,000. Eastern Bank increased its holdings in shares of Nutrien by 133.0% during the fourth quarter. Eastern Bank now owns 699 shares of the company’s stock valued at $43,000 after acquiring an additional 399 shares in the last quarter. Harbour Investments Inc. increased its holdings in shares of Nutrien by 97.2% during the fourth quarter. Harbour Investments Inc. now owns 704 shares of the company’s stock valued at $43,000 after acquiring an additional 347 shares in the last quarter. Finally, Geneos Wealth Management Inc. raised its position in shares of Nutrien by 42.4% during the second quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock worth $43,000 after purchasing an additional 219 shares during the period. 63.10% of the stock is owned by institutional investors.

Nutrien Stock Down 0.0%

NTR stock opened at $65.04 on Friday. Nutrien Ltd. has a twelve month low of $53.03 and a twelve month high of $85.36. The company has a quick ratio of 0.59, a current ratio of 1.24 and a debt-to-equity ratio of 0.35. The stock’s 50 day moving average is $68.12 and its 200-day moving average is $69.58. The firm has a market capitalization of $31.17 billion, a PE ratio of 13.25, a P/E/G ratio of 0.60 and a beta of 0.62.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.03. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The company had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $5.30 billion. During the same quarter in the previous year, the firm earned $0.11 earnings per share. Nutrien’s quarterly revenue was up 18.5% on a year-over-year basis. Sell-side analysts expect that Nutrien Ltd. will post 5.45 EPS for the current fiscal year.

Nutrien Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 17th. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date of this dividend is Tuesday, June 30th. Nutrien’s payout ratio is currently 44.81%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Berenberg Bank set a $65.00 target price on Nutrien and gave the stock a “hold” rating in a report on Wednesday, June 10th. Wells Fargo & Company upgraded shares of Nutrien from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $77.00 to $100.00 in a research note on Friday, March 13th. JPMorgan Chase & Co. upped their price objective on shares of Nutrien from $78.00 to $80.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Weiss Ratings raised shares of Nutrien from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, June 1st. Finally, Jefferies Financial Group upgraded shares of Nutrien from a “hold” rating to a “buy” rating and lifted their price objective for the company from $74.00 to $96.00 in a report on Thursday, March 12th. Thirteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $81.61.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.